Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm

Enrolling by invitation

Phase N/A Results N/A

Summary of Purpose

The objective of this study is to determine whether acetaminophen (APAP), N-acetylcysteine (NAC), and APAP in combination with NAC will inhibit lipid peroxidation in aneurysmal subarachnoid hemorrhage (aSAH), utilizing F2-IsoPs as biomarkers for lipid peroxidation.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 March 2018.

1 Apr 2007 26 Dec 2007 1 Jul 2020 1 Dec 2020 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Factorial Assignment


Not available